SCOPUS 정보 검색 플랫폼

Volumn 32, Issue 3, 2009, Pages

Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the american diabetes association and the european association for the study of diabetes

(1) Eizirik, Decio L a

a FREE UNIVERSITY OF BRUSSELS (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ALGORITHM; COST BENEFIT ANALYSIS; DIABETIC PATIENT; HUMAN; HYPERGLYCEMIA; LETTER; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS;

ALGORITHMS; DIABETES MELLITUS, TYPE 2; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 64749107235 PISSN: 01495992 EISSN: 19355548 Source Type: Journal
DOI: 10.2337/dc08-2275 Document Type: Letter

Times cited : (7)

References (6)

1
- 64749100501
- Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193-203, 2009
- (2009) Diabetes Care , vol.32 , pp. 193-203
- Nathan, D.M.¹ Buse, J.B.² Davidson, M.B.³ Ferrannini, E.⁴ Holman, R.R.⁵ Sherwin, R.⁶ Zinman, B.⁷

2
- 2942666092
- The Endocrine Society Ethics Advisory Committee: Ethical aspects of conflicts of interest, October 2003
- Endocrine Society Ethics Advisory Committee
- Komesaroff PA, Bach MA, Danoff A, Grumbach MM, Kaplan S, Lakoski JM, Leitman D, Mellon S, Underwood LE, Leupen S, Endocrine Society Ethics Advisory Committee: The Endocrine Society Ethics Advisory Committee: ethical aspects of conflicts of interest, October 2003. Endocrinology 145:3032-3041, 2004
- (2004) Endocrinology , vol.145 , pp. 3032-3041
- Komesaroff, P.A.¹ Bach, M.A.² Danoff, A.³ Grumbach, M.M.⁴ Kaplan, S.⁵ Lakoski, J.M.⁶ Leitman, D.⁷ Mellon, S.⁸ Underwood, L.E.⁹ Leupen, S.¹⁰

3
- 0027297206
- Understanding financial conflicts of interest
- Thomson DF: Understanding financial conflicts of interest. N Engl J Med 329: 573-576, 1993
- (1993) N Engl J Med , vol.329 , pp. 573-576
- Thomson, D.F.¹

4
- 0037460196
- Scope and impact of financial conflicts of interest in biomedical research: A systematic review
- Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454-465, 2003
- (2003) JAMA , vol.289 , pp. 454-465
- Bekelman, J.E.¹ Li, Y.² Gross, C.P.³

5
- 33644842804
- Ethical issues in the relationships with industry: An ongoing challenge. New guidelines open for public comment
- Komesaroff PA: Ethical issues in the relationships with industry: an ongoing challenge. New guidelines open for public comment. J Paediatr Child Health 41:558-560, 2005
- (2005) J Paediatr Child Health , vol.41 , pp. 558-560
- Komesaroff, P.A.¹

6
- 0348142059
- Between two cultures: The expert clinician and the pharmaceutical industry
- Gale EA: Between two cultures: the expert clinician and the pharmaceutical industry. Clin Med 3:538-541, 2003
- (2003) Clin Med , vol.3 , pp. 538-541
- Gale, E.A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.